Evidence map›Paper›PMID 34445233›Full record

ReviewInternational journal of molecular sciences2021

The Contribution of Autophagy and LncRNAs to MYC-Driven Gene Regulatory Networks in Cancers.

Leila Jahangiri, Perla Pucci, Tala Ishola, Ricky M Trigg, John A Williams, Joao Pereira, Megan L Cavanagh, Suzanne D Turner, Georgios V Gkoutos, Loukia Tsaprouni

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Long Non-Coding RNAs as "MYC Facilitators".Pathophysiology : the official journal of the International Society for Pathophysiology · 2023
    Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Leila JahangiriDepartment of Life Sciences, Birmingham City University, Birmingham B15 3TN, UK.ORCID 0000-0003-0235-8447
Perla PucciDivision of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge CB2 0QQ, UK.ORCID 0000-0003-1264-3487
Tala IsholaDepartment of Life Sciences, Birmingham City University, Birmingham B15 3TN, UK.
Ricky M TriggDepartment of Functional Genomics, GlaxoSmithKline, Stevenage SG1 2NY, UK.
John A WilliamsInstitute of Translational Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TH, UK.ORCID 0000-0002-0357-5454
Joao PereiraDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Megan L CavanaghDepartment of Life Sciences, Birmingham City University, Birmingham B15 3TN, UK.
Suzanne D TurnerDivision of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge CB2 0QQ, UK.ORCID 0000-0002-8439-4507
Georgios V GkoutosInstitute of Translational Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TH, UK.ORCID 0000-0002-2061-091X
Loukia TsaprouniDepartment of Life Sciences, Birmingham City University, Birmingham B15 3TN, UK.ORCID 0000-0002-4740-3099
Birmingham City University · GBUniversity Hospitals Birmingham NHS Foundation Trust · GBUniversity of Cambridge · GBGlaxoSmithKline (United Kingdom) · GBHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MYC is a target of the Wnt signalling pathway and governs numerous cellular and developmental programmes hijacked in cancers. The amplification of MYC is a frequently occurring genetic alteration in cancer genomes, and this transcription factor is implicated in metabolic reprogramming, cell death, and angiogenesis in cancers. In this review, we analyse MYC gene networks in solid cancers. We investigate the interaction of MYC with long non-coding RNAs (lncRNAs). Furthermore, we investigate the role of MYC regulatory networks in inducing changes to cellular processes, including autophagy and mitophagy. Finally, we review the interaction and mutual regulation between MYC and lncRNAs, and autophagic processes and analyse these networks as unexplored areas of targeting and manipulation for therapeutic gain in MYC-driven malignancies.

Indexed as

AutophagyGene Expression Regulation, NeoplasticGene Regulatory NetworksAnimalsHumansProto-Oncogene Proteins c-mycRNA, Long NoncodingRNA, NeoplasmMYC protein, humanProto-Oncogene Proteins c-mycRNA, Long NoncodingRNA, Neoplasmautophagygene regulatory networks (GRNs)lncRNAsMYC

Identifiers

PMID34445233
PMCPMC8395220
OpenAlexW3187356964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.